Review



gb21303 apc anti mouse cd8a antibody proteintech  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech gb21303 apc anti mouse cd8a antibody proteintech
    Gb21303 Apc Anti Mouse Cd8a Antibody Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/APC+Anti-mouse+CD8a/pm42810343-283-261-266
    Average 93 stars, based on 16 article reviews
    gb21303 apc anti mouse cd8a antibody proteintech - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    Expressing:

    Article Title: Aberrant expression of triggering receptor expressed on myeloid cell-1 is involved in the immunopathological mechanism of myasthenia gravis.
    Article Snippet: .. Expression levels of TREM-1 on immune cell subsets (CD4+T cells, CD8+T cells, B cells, NK cells, neutrophils, and monocytes) were detected in 20 MG patients and 20 HC by surface marker staining with anti-CD3-BV605 (Cat#344836, Biolegend, San Diego, CA, USA), anti-CD4-PerCP-CY5.5 (Cat#317427, Biolegend, San Diego, CA, USA), anti-CD8-APC (Cat#APC-65113, Proteintech Group, Chicago, IL, USA), anti-CD19-FITC (Cat#E-ABF1004C, Elabscience Biotechnology Co., Ltd), anti-CD56-APC, (Cat#362504, Biolegend, San Diego, CA, USA), CD45-FITC (Cat#304006, Biolegend, San Diego, CA, USA), CD11b-APC (Cat#301310, Biolegend, San Diego, CA, USA), CD14-FITC (Cat#FITC-65246, Proteintech Group, Chicago, IL, USA), and antiTREM-1-PE (Cat#314906, Biolegend, San Diego, CA, USA). ..

    Marker:

    Article Title: Aberrant expression of triggering receptor expressed on myeloid cell-1 is involved in the immunopathological mechanism of myasthenia gravis.
    Article Snippet: .. Expression levels of TREM-1 on immune cell subsets (CD4+T cells, CD8+T cells, B cells, NK cells, neutrophils, and monocytes) were detected in 20 MG patients and 20 HC by surface marker staining with anti-CD3-BV605 (Cat#344836, Biolegend, San Diego, CA, USA), anti-CD4-PerCP-CY5.5 (Cat#317427, Biolegend, San Diego, CA, USA), anti-CD8-APC (Cat#APC-65113, Proteintech Group, Chicago, IL, USA), anti-CD19-FITC (Cat#E-ABF1004C, Elabscience Biotechnology Co., Ltd), anti-CD56-APC, (Cat#362504, Biolegend, San Diego, CA, USA), CD45-FITC (Cat#304006, Biolegend, San Diego, CA, USA), CD11b-APC (Cat#301310, Biolegend, San Diego, CA, USA), CD14-FITC (Cat#FITC-65246, Proteintech Group, Chicago, IL, USA), and antiTREM-1-PE (Cat#314906, Biolegend, San Diego, CA, USA). ..

    Staining:

    Article Title: Aberrant expression of triggering receptor expressed on myeloid cell-1 is involved in the immunopathological mechanism of myasthenia gravis.
    Article Snippet: .. Expression levels of TREM-1 on immune cell subsets (CD4+T cells, CD8+T cells, B cells, NK cells, neutrophils, and monocytes) were detected in 20 MG patients and 20 HC by surface marker staining with anti-CD3-BV605 (Cat#344836, Biolegend, San Diego, CA, USA), anti-CD4-PerCP-CY5.5 (Cat#317427, Biolegend, San Diego, CA, USA), anti-CD8-APC (Cat#APC-65113, Proteintech Group, Chicago, IL, USA), anti-CD19-FITC (Cat#E-ABF1004C, Elabscience Biotechnology Co., Ltd), anti-CD56-APC, (Cat#362504, Biolegend, San Diego, CA, USA), CD45-FITC (Cat#304006, Biolegend, San Diego, CA, USA), CD11b-APC (Cat#301310, Biolegend, San Diego, CA, USA), CD14-FITC (Cat#FITC-65246, Proteintech Group, Chicago, IL, USA), and antiTREM-1-PE (Cat#314906, Biolegend, San Diego, CA, USA). ..

    Article Title: An engineered linear cap-independent mRNA vaccine with intrinsic adjuvanticity induces potent anti-tumor immunity in mice.
    Article Snippet: For intra-cellular IFNγ staining, PBMCs or splenocytes were separated by Mouse 1× Lymphocyte Separation Medium (DAKEWE, Shenzhen) according to the manufacturer’s instructions. .. Cells were then stained with Fixable Viability Dye eFluor 450 (65-0863-14, eBioscience), anti-CD3 (APC-65077, Proteintech), anti-CD8a at 4°C for 30min. .. Subsequently, cells were fixed and permeabilized with Intracellular Fixation and Permeabilization Buffer Set (eBioscience) according to the manufacturer’s instructions, and stained with antiIFNγ (PE, 163503, Biolegend) at room temperature for 20min, and analyzed by CytoFLEX Flow Cytometer (Beckman).

    Recombinant:

    Article Title: Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies APC/Cyanine7 anti-human CD45 Antibody Biolegend Cat# 304014; RRID: AB_314402 PerCP/Cyanine5.5 anti-mouse CD3 Biolegend Cat# 100218; RRID: AB_1595492 APC anti-mouse CD4 Antibody Biolegend Cat# 100515; RRID: AB_312718 Brilliant Violet 510TM anti-mouse CD8a Antibody Biolegend Cat# 100753; RRID: AB_2563057 APC anti-mouse NK-1.1 Antibody Biolegend Cat# 108709; RRID: AB_313396 FITC anti-mouse CD11b Antibody Biolegend Cat# 101205; RRID: AB_312788 PE anti-mouse F4/80 Antibody Biolegend Cat# 123110; RRID: AB_893486 PE/Cyanine7 anti-mouse CD206 (MMR) Antibody Biolegend Cat# 141720; RRID: AB_2562248 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 PE/Cyanine7 anti-mouse CD11c Antibody Biolegend Cat# 117318; RRID: AB_493568 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 Brilliant Violet 510 anti-mouse CD80 Biolegend Cat# 104741; RRID: AB_2810337 APC anti-mouse CD45 Antibody Biolegend Cat# 147707; RRID: AB_2563539 PE anti-mouse Ly-6G Antibody Biolegend Cat# 164503; RRID: AB_2904311 APC anti-human/mouse Granzyme B Recombinant Antibody Biolegend Cat# 372203; RRID: AB_2687027 APC anti-mouse IFN-γ Antibody Biolegend Cat# 505809; RRID: AB_315403 APC anti-mouse Ki-67 Antibody Biolegend Cat# 652405; RRID: AB_2561929 Recombinant Anti-CD11c antibody (Rabbit mAb) Servicebio Cat# GB155690 Anti-F4/80 Rabbit pAb Servicebio Cat# GB113373 Recombinant Anti-CD86 antibody (Rabbit mAb) Servicebio Cat# GB150054 Anti-Ly6G Rabbit pAb Servicebio Cat# GB11229 Anti-Myeloperoxidase Rabbit pAb Servicebio Cat# GB11224 Anti-LAMP1 Rabbit pAb Servicebio Cat# GB112949 Anti-CD3 Rabbit pAb Servicebio Cat# GB11014 S-Vision immunohistochemical polymer secondary antibody (Goat anti-Rabbit) Servicebio Cat# G1302 Recombinant Anti-His Tag antibody (Rabbit mAb) Servicebio Cat# GB151255 Cy5 conjugated Goat Anti-rabbit IgG (H + L) Servicebio Cat# GB27303 FITC conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB22303 Cy3 conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB21303 APC anti-mouse cd8a Antibody proteintech Cat# APC-65069; RRID: AB_2882970 FOXP3 Monoclonal Antibody (FJK-16s), PE, eBioscience Cat# 12–5773-82; RRID: AB_465936 Ki67 Rabbit Polyclonal Antibody Beyotime Cat# AB2008 NK1.1/CD161 (E6Y9G) Rabbit Monoclonal Antibody Cell Signaling Technology Cat# 39197T Bacterial and virus strains E. coli. .. MG1655 Miaoling Bioscience ATCC 47076 pUC19 plasmid Miaoling Bioscience Cat# P0368 Biological samples Mouse spleen tissues C57BL/6 N/A Mouse lymph node tissues C57BL/6 N/A (Continued on next page) Cell Reports Medicine 7, 103082, October 20, 2026 e1 Article ll OPEN ACCESS

    Immunohistochemical staining:

    Article Title: Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies APC/Cyanine7 anti-human CD45 Antibody Biolegend Cat# 304014; RRID: AB_314402 PerCP/Cyanine5.5 anti-mouse CD3 Biolegend Cat# 100218; RRID: AB_1595492 APC anti-mouse CD4 Antibody Biolegend Cat# 100515; RRID: AB_312718 Brilliant Violet 510TM anti-mouse CD8a Antibody Biolegend Cat# 100753; RRID: AB_2563057 APC anti-mouse NK-1.1 Antibody Biolegend Cat# 108709; RRID: AB_313396 FITC anti-mouse CD11b Antibody Biolegend Cat# 101205; RRID: AB_312788 PE anti-mouse F4/80 Antibody Biolegend Cat# 123110; RRID: AB_893486 PE/Cyanine7 anti-mouse CD206 (MMR) Antibody Biolegend Cat# 141720; RRID: AB_2562248 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 PE/Cyanine7 anti-mouse CD11c Antibody Biolegend Cat# 117318; RRID: AB_493568 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 Brilliant Violet 510 anti-mouse CD80 Biolegend Cat# 104741; RRID: AB_2810337 APC anti-mouse CD45 Antibody Biolegend Cat# 147707; RRID: AB_2563539 PE anti-mouse Ly-6G Antibody Biolegend Cat# 164503; RRID: AB_2904311 APC anti-human/mouse Granzyme B Recombinant Antibody Biolegend Cat# 372203; RRID: AB_2687027 APC anti-mouse IFN-γ Antibody Biolegend Cat# 505809; RRID: AB_315403 APC anti-mouse Ki-67 Antibody Biolegend Cat# 652405; RRID: AB_2561929 Recombinant Anti-CD11c antibody (Rabbit mAb) Servicebio Cat# GB155690 Anti-F4/80 Rabbit pAb Servicebio Cat# GB113373 Recombinant Anti-CD86 antibody (Rabbit mAb) Servicebio Cat# GB150054 Anti-Ly6G Rabbit pAb Servicebio Cat# GB11229 Anti-Myeloperoxidase Rabbit pAb Servicebio Cat# GB11224 Anti-LAMP1 Rabbit pAb Servicebio Cat# GB112949 Anti-CD3 Rabbit pAb Servicebio Cat# GB11014 S-Vision immunohistochemical polymer secondary antibody (Goat anti-Rabbit) Servicebio Cat# G1302 Recombinant Anti-His Tag antibody (Rabbit mAb) Servicebio Cat# GB151255 Cy5 conjugated Goat Anti-rabbit IgG (H + L) Servicebio Cat# GB27303 FITC conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB22303 Cy3 conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB21303 APC anti-mouse cd8a Antibody proteintech Cat# APC-65069; RRID: AB_2882970 FOXP3 Monoclonal Antibody (FJK-16s), PE, eBioscience Cat# 12–5773-82; RRID: AB_465936 Ki67 Rabbit Polyclonal Antibody Beyotime Cat# AB2008 NK1.1/CD161 (E6Y9G) Rabbit Monoclonal Antibody Cell Signaling Technology Cat# 39197T Bacterial and virus strains E. coli. .. MG1655 Miaoling Bioscience ATCC 47076 pUC19 plasmid Miaoling Bioscience Cat# P0368 Biological samples Mouse spleen tissues C57BL/6 N/A Mouse lymph node tissues C57BL/6 N/A (Continued on next page) Cell Reports Medicine 7, 103082, October 20, 2026 e1 Article ll OPEN ACCESS

    Polymer:

    Article Title: Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies APC/Cyanine7 anti-human CD45 Antibody Biolegend Cat# 304014; RRID: AB_314402 PerCP/Cyanine5.5 anti-mouse CD3 Biolegend Cat# 100218; RRID: AB_1595492 APC anti-mouse CD4 Antibody Biolegend Cat# 100515; RRID: AB_312718 Brilliant Violet 510TM anti-mouse CD8a Antibody Biolegend Cat# 100753; RRID: AB_2563057 APC anti-mouse NK-1.1 Antibody Biolegend Cat# 108709; RRID: AB_313396 FITC anti-mouse CD11b Antibody Biolegend Cat# 101205; RRID: AB_312788 PE anti-mouse F4/80 Antibody Biolegend Cat# 123110; RRID: AB_893486 PE/Cyanine7 anti-mouse CD206 (MMR) Antibody Biolegend Cat# 141720; RRID: AB_2562248 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 PE/Cyanine7 anti-mouse CD11c Antibody Biolegend Cat# 117318; RRID: AB_493568 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 Brilliant Violet 510 anti-mouse CD80 Biolegend Cat# 104741; RRID: AB_2810337 APC anti-mouse CD45 Antibody Biolegend Cat# 147707; RRID: AB_2563539 PE anti-mouse Ly-6G Antibody Biolegend Cat# 164503; RRID: AB_2904311 APC anti-human/mouse Granzyme B Recombinant Antibody Biolegend Cat# 372203; RRID: AB_2687027 APC anti-mouse IFN-γ Antibody Biolegend Cat# 505809; RRID: AB_315403 APC anti-mouse Ki-67 Antibody Biolegend Cat# 652405; RRID: AB_2561929 Recombinant Anti-CD11c antibody (Rabbit mAb) Servicebio Cat# GB155690 Anti-F4/80 Rabbit pAb Servicebio Cat# GB113373 Recombinant Anti-CD86 antibody (Rabbit mAb) Servicebio Cat# GB150054 Anti-Ly6G Rabbit pAb Servicebio Cat# GB11229 Anti-Myeloperoxidase Rabbit pAb Servicebio Cat# GB11224 Anti-LAMP1 Rabbit pAb Servicebio Cat# GB112949 Anti-CD3 Rabbit pAb Servicebio Cat# GB11014 S-Vision immunohistochemical polymer secondary antibody (Goat anti-Rabbit) Servicebio Cat# G1302 Recombinant Anti-His Tag antibody (Rabbit mAb) Servicebio Cat# GB151255 Cy5 conjugated Goat Anti-rabbit IgG (H + L) Servicebio Cat# GB27303 FITC conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB22303 Cy3 conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB21303 APC anti-mouse cd8a Antibody proteintech Cat# APC-65069; RRID: AB_2882970 FOXP3 Monoclonal Antibody (FJK-16s), PE, eBioscience Cat# 12–5773-82; RRID: AB_465936 Ki67 Rabbit Polyclonal Antibody Beyotime Cat# AB2008 NK1.1/CD161 (E6Y9G) Rabbit Monoclonal Antibody Cell Signaling Technology Cat# 39197T Bacterial and virus strains E. coli. .. MG1655 Miaoling Bioscience ATCC 47076 pUC19 plasmid Miaoling Bioscience Cat# P0368 Biological samples Mouse spleen tissues C57BL/6 N/A Mouse lymph node tissues C57BL/6 N/A (Continued on next page) Cell Reports Medicine 7, 103082, October 20, 2026 e1 Article ll OPEN ACCESS

    Cell-Signaling:

    Article Title: Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies APC/Cyanine7 anti-human CD45 Antibody Biolegend Cat# 304014; RRID: AB_314402 PerCP/Cyanine5.5 anti-mouse CD3 Biolegend Cat# 100218; RRID: AB_1595492 APC anti-mouse CD4 Antibody Biolegend Cat# 100515; RRID: AB_312718 Brilliant Violet 510TM anti-mouse CD8a Antibody Biolegend Cat# 100753; RRID: AB_2563057 APC anti-mouse NK-1.1 Antibody Biolegend Cat# 108709; RRID: AB_313396 FITC anti-mouse CD11b Antibody Biolegend Cat# 101205; RRID: AB_312788 PE anti-mouse F4/80 Antibody Biolegend Cat# 123110; RRID: AB_893486 PE/Cyanine7 anti-mouse CD206 (MMR) Antibody Biolegend Cat# 141720; RRID: AB_2562248 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 PE/Cyanine7 anti-mouse CD11c Antibody Biolegend Cat# 117318; RRID: AB_493568 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 Brilliant Violet 510 anti-mouse CD80 Biolegend Cat# 104741; RRID: AB_2810337 APC anti-mouse CD45 Antibody Biolegend Cat# 147707; RRID: AB_2563539 PE anti-mouse Ly-6G Antibody Biolegend Cat# 164503; RRID: AB_2904311 APC anti-human/mouse Granzyme B Recombinant Antibody Biolegend Cat# 372203; RRID: AB_2687027 APC anti-mouse IFN-γ Antibody Biolegend Cat# 505809; RRID: AB_315403 APC anti-mouse Ki-67 Antibody Biolegend Cat# 652405; RRID: AB_2561929 Recombinant Anti-CD11c antibody (Rabbit mAb) Servicebio Cat# GB155690 Anti-F4/80 Rabbit pAb Servicebio Cat# GB113373 Recombinant Anti-CD86 antibody (Rabbit mAb) Servicebio Cat# GB150054 Anti-Ly6G Rabbit pAb Servicebio Cat# GB11229 Anti-Myeloperoxidase Rabbit pAb Servicebio Cat# GB11224 Anti-LAMP1 Rabbit pAb Servicebio Cat# GB112949 Anti-CD3 Rabbit pAb Servicebio Cat# GB11014 S-Vision immunohistochemical polymer secondary antibody (Goat anti-Rabbit) Servicebio Cat# G1302 Recombinant Anti-His Tag antibody (Rabbit mAb) Servicebio Cat# GB151255 Cy5 conjugated Goat Anti-rabbit IgG (H + L) Servicebio Cat# GB27303 FITC conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB22303 Cy3 conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB21303 APC anti-mouse cd8a Antibody proteintech Cat# APC-65069; RRID: AB_2882970 FOXP3 Monoclonal Antibody (FJK-16s), PE, eBioscience Cat# 12–5773-82; RRID: AB_465936 Ki67 Rabbit Polyclonal Antibody Beyotime Cat# AB2008 NK1.1/CD161 (E6Y9G) Rabbit Monoclonal Antibody Cell Signaling Technology Cat# 39197T Bacterial and virus strains E. coli. .. MG1655 Miaoling Bioscience ATCC 47076 pUC19 plasmid Miaoling Bioscience Cat# P0368 Biological samples Mouse spleen tissues C57BL/6 N/A Mouse lymph node tissues C57BL/6 N/A (Continued on next page) Cell Reports Medicine 7, 103082, October 20, 2026 e1 Article ll OPEN ACCESS

    Virus:

    Article Title: Reversal of the neutrophil barrier for potentiating immune-engineered bacteria therapy in pancreatic cancer.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies APC/Cyanine7 anti-human CD45 Antibody Biolegend Cat# 304014; RRID: AB_314402 PerCP/Cyanine5.5 anti-mouse CD3 Biolegend Cat# 100218; RRID: AB_1595492 APC anti-mouse CD4 Antibody Biolegend Cat# 100515; RRID: AB_312718 Brilliant Violet 510TM anti-mouse CD8a Antibody Biolegend Cat# 100753; RRID: AB_2563057 APC anti-mouse NK-1.1 Antibody Biolegend Cat# 108709; RRID: AB_313396 FITC anti-mouse CD11b Antibody Biolegend Cat# 101205; RRID: AB_312788 PE anti-mouse F4/80 Antibody Biolegend Cat# 123110; RRID: AB_893486 PE/Cyanine7 anti-mouse CD206 (MMR) Antibody Biolegend Cat# 141720; RRID: AB_2562248 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 PE/Cyanine7 anti-mouse CD11c Antibody Biolegend Cat# 117318; RRID: AB_493568 APC anti-mouse CD86 Antibody Biolegend Cat# 105012; RRID: AB_493342 Brilliant Violet 510 anti-mouse CD80 Biolegend Cat# 104741; RRID: AB_2810337 APC anti-mouse CD45 Antibody Biolegend Cat# 147707; RRID: AB_2563539 PE anti-mouse Ly-6G Antibody Biolegend Cat# 164503; RRID: AB_2904311 APC anti-human/mouse Granzyme B Recombinant Antibody Biolegend Cat# 372203; RRID: AB_2687027 APC anti-mouse IFN-γ Antibody Biolegend Cat# 505809; RRID: AB_315403 APC anti-mouse Ki-67 Antibody Biolegend Cat# 652405; RRID: AB_2561929 Recombinant Anti-CD11c antibody (Rabbit mAb) Servicebio Cat# GB155690 Anti-F4/80 Rabbit pAb Servicebio Cat# GB113373 Recombinant Anti-CD86 antibody (Rabbit mAb) Servicebio Cat# GB150054 Anti-Ly6G Rabbit pAb Servicebio Cat# GB11229 Anti-Myeloperoxidase Rabbit pAb Servicebio Cat# GB11224 Anti-LAMP1 Rabbit pAb Servicebio Cat# GB112949 Anti-CD3 Rabbit pAb Servicebio Cat# GB11014 S-Vision immunohistochemical polymer secondary antibody (Goat anti-Rabbit) Servicebio Cat# G1302 Recombinant Anti-His Tag antibody (Rabbit mAb) Servicebio Cat# GB151255 Cy5 conjugated Goat Anti-rabbit IgG (H + L) Servicebio Cat# GB27303 FITC conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB22303 Cy3 conjugated Goat Anti-Rabbit IgG (H + L) Servicebio Cat# GB21303 APC anti-mouse cd8a Antibody proteintech Cat# APC-65069; RRID: AB_2882970 FOXP3 Monoclonal Antibody (FJK-16s), PE, eBioscience Cat# 12–5773-82; RRID: AB_465936 Ki67 Rabbit Polyclonal Antibody Beyotime Cat# AB2008 NK1.1/CD161 (E6Y9G) Rabbit Monoclonal Antibody Cell Signaling Technology Cat# 39197T Bacterial and virus strains E. coli. .. MG1655 Miaoling Bioscience ATCC 47076 pUC19 plasmid Miaoling Bioscience Cat# P0368 Biological samples Mouse spleen tissues C57BL/6 N/A Mouse lymph node tissues C57BL/6 N/A (Continued on next page) Cell Reports Medicine 7, 103082, October 20, 2026 e1 Article ll OPEN ACCESS

    other:

    Article Title: Innovative DNA tetrahedron inspired by ancient mortise-and-tenon technique offers new immunotherapy strategy for metastatic breast cancer.
    Article Snippet: Framework nucleic acids effectively meet the demands for precise size control and accurate targeting in the design of drug delivery systems, while developing a controllable drug delivery system with low immunogenicity and high efficiency for delivering nucleic acid drugs to the tumor immune microenvironment (TIME) remains significant challenge.. Inspired by ancient Chinese mortise and tenon joint structures, this study develops an intelligent self-assembling DNA tetrahedron (TDN@siCSF-1R), which consists of a gapped DNA tetrahedron (TDN) and a therapeutic siRNA against Colony-Stimulating Factor-1 Receptor (siCSF-1R) that non-covalently bind with TDN via its gap, aiming to target tumor-associated macrophages (TAMs) and inhibit the CSF-1R pathway.. Additionally, a CD206 mRNA-responsive sequence is introduced into the gapped TDN, triggering the site-specific release of siCSF-1R in M2-like TAMs, thereby achieving the precise targeting of CSF-1R in M2-like TAMs and reducing off-target effect.

    Article Title: A Porphyrin Nanomaterial for Photoimmunotherapy for Treatment of Melanoma.
    Article Snippet: Materials: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and ovalbumin were purchased from Shanghai yuanye Bio-Technology Co., Ltd. Anti-HMGB1 antibody, anti-Calreticulin (CRT), Donkey Anti-rabbit IgG/FITC, anti-Mouse CD86-FITC, Gr-1-PE, CD80-PE, CD11c-APC, CD8a-APC, CD11b-APC, CD3ε-FITC, BCA Protein Assay kit and Mouse TNF-α Elisa Kit and IFN-γ were purchased from Proteintech Co, Ltd Enhanced ATP Assay Kit was purchased from Beyotime Co, Ltd.

    Suspension:

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2
    Article Snippet: The cells were resuspended with BeyoFC cell staining buffer (C1711, Beyotime), and the cell concentration was adjusted to 1 × 10 7 cells/mL. .. The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C. .. After completion of surface antigen staining, the cells were incubated with 4% PFA fixation buffer for 20 min, with BeyoFC cell permeabilization and wash buffer (C1717, Beyotime) for 10 min (both at RT), and with PE-CY7-coupled GZMB antibody (1:200, 25-8898-82, Thermo Fisher Scientific Inc., RRID: AB_10853339) at 4 °C for 1 h. All the procedures above were conducted in the dark.

    Incubation:

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2
    Article Snippet: The cells were resuspended with BeyoFC cell staining buffer (C1711, Beyotime), and the cell concentration was adjusted to 1 × 10 7 cells/mL. .. The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C. .. After completion of surface antigen staining, the cells were incubated with 4% PFA fixation buffer for 20 min, with BeyoFC cell permeabilization and wash buffer (C1717, Beyotime) for 10 min (both at RT), and with PE-CY7-coupled GZMB antibody (1:200, 25-8898-82, Thermo Fisher Scientific Inc., RRID: AB_10853339) at 4 °C for 1 h. All the procedures above were conducted in the dark.

    Blocking Assay:

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2
    Article Snippet: The cells were resuspended with BeyoFC cell staining buffer (C1711, Beyotime), and the cell concentration was adjusted to 1 × 10 7 cells/mL. .. The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C. .. After completion of surface antigen staining, the cells were incubated with 4% PFA fixation buffer for 20 min, with BeyoFC cell permeabilization and wash buffer (C1717, Beyotime) for 10 min (both at RT), and with PE-CY7-coupled GZMB antibody (1:200, 25-8898-82, Thermo Fisher Scientific Inc., RRID: AB_10853339) at 4 °C for 1 h. All the procedures above were conducted in the dark.

    FACS:

    Article Title: Oral microbiota-responsive ZIF nanoplatform via double-layer glycans modified combined with PD-1 inhibitor for treatment of microsatellite-stable colorectal cancer
    Article Snippet: Inulin was acquired from Macklin Biochemical Technology Co., Ltd. (Shanghai, China). .. Antibodies for FACS analysis, including KO525 Fixable Viability Dye, Purified anti-mouse CD16/32 Antibody, PB450 anti-mouse CD45 Antibody, FITC anti-mouse CD3 Antibody, BV510 anti-mouse CD4 Antibody, APC anti-mouse CD8a Antibody, PE anti-mouse Granzyme B Antibody, PC7 anti-mouse IFN-γ Antibody, APC anti-mouse CD11c Antibody, APC-A700 anti-mouse I-A/I-E Antibody, and PE anti-mouse CD86 Antibody were sourced from Biolegend Inc. HMGB1 Rabbit PolyAb and Calreticulin Rabbit PolyAb were sourced from Proteintech Group, Inc. ..

    Analysis:

    Article Title: Oral microbiota-responsive ZIF nanoplatform via double-layer glycans modified combined with PD-1 inhibitor for treatment of microsatellite-stable colorectal cancer
    Article Snippet: Inulin was acquired from Macklin Biochemical Technology Co., Ltd. (Shanghai, China). .. Antibodies for FACS analysis, including KO525 Fixable Viability Dye, Purified anti-mouse CD16/32 Antibody, PB450 anti-mouse CD45 Antibody, FITC anti-mouse CD3 Antibody, BV510 anti-mouse CD4 Antibody, APC anti-mouse CD8a Antibody, PE anti-mouse Granzyme B Antibody, PC7 anti-mouse IFN-γ Antibody, APC anti-mouse CD11c Antibody, APC-A700 anti-mouse I-A/I-E Antibody, and PE anti-mouse CD86 Antibody were sourced from Biolegend Inc. HMGB1 Rabbit PolyAb and Calreticulin Rabbit PolyAb were sourced from Proteintech Group, Inc. ..

    Purification:

    Article Title: Oral microbiota-responsive ZIF nanoplatform via double-layer glycans modified combined with PD-1 inhibitor for treatment of microsatellite-stable colorectal cancer
    Article Snippet: Inulin was acquired from Macklin Biochemical Technology Co., Ltd. (Shanghai, China). .. Antibodies for FACS analysis, including KO525 Fixable Viability Dye, Purified anti-mouse CD16/32 Antibody, PB450 anti-mouse CD45 Antibody, FITC anti-mouse CD3 Antibody, BV510 anti-mouse CD4 Antibody, APC anti-mouse CD8a Antibody, PE anti-mouse Granzyme B Antibody, PC7 anti-mouse IFN-γ Antibody, APC anti-mouse CD11c Antibody, APC-A700 anti-mouse I-A/I-E Antibody, and PE anti-mouse CD86 Antibody were sourced from Biolegend Inc. HMGB1 Rabbit PolyAb and Calreticulin Rabbit PolyAb were sourced from Proteintech Group, Inc. ..



    Similar Products

    93
    Proteintech gb21303 apc anti mouse cd8a antibody proteintech
    Gb21303 Apc Anti Mouse Cd8a Antibody Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/APC+Anti-mouse+CD8a/pm42810343-283-261-266
    Average 93 stars, based on 1 article reviews
    gb21303 apc anti mouse cd8a antibody proteintech - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    91
    Cytek Biosciences cd8a
    Cd8a, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/APC+Anti-Human+CD8a/10__1021_slash_acsnano__6c11865-448-42-46
    Average 91 stars, based on 1 article reviews
    cd8a - by Bioz Stars, 2026-11
    91/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti cd8 apc
    Anti Cd8 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/CD8a+Antibody%2C+anti-mouse%2C+REAfinity/pmc13355016-9-0-2
    Average 94 stars, based on 1 article reviews
    anti cd8 apc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology cd8a apc
    Cd8a Apc, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/APC+Anti-Rat+CD8a+Antibody/pm41612708-289-13-17
    Average 94 stars, based on 1 article reviews
    cd8a apc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology apc anti mouse cd8a antibody
    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured <t>CD8</t> + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.
    Apc Anti Mouse Cd8a Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/APC+Anti-Mouse+CD8a+Antibody/pmc13053763-26-0-5
    Average 94 stars, based on 1 article reviews
    apc anti mouse cd8a antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Elabscience Biotechnology e ab f1104e rrid ab 3740201
    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured <t>CD8</t> + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.
    E Ab F1104e Rrid Ab 3740201, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/APC+Anti-Mouse+CD8a+Antibody/pmc13053763-26-8-5
    Average 94 stars, based on 1 article reviews
    e ab f1104e rrid ab 3740201 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Proteintech anti cd8a
    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured <t>CD8</t> + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.
    Anti Cd8a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/APC+Anti-mouse+CD3/pm41748617-317-15-14
    Average 93 stars, based on 1 article reviews
    anti cd8a - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    95
    ABclonal Biotechnology apc rat anti mouse cd8a
    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured <t>CD8</t> + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.
    Apc Rat Anti Mouse Cd8a, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/CD8A+Rabbit+pAb/pm41734761-926-16-14
    Average 95 stars, based on 1 article reviews
    apc rat anti mouse cd8a - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    93
    Proteintech apc coupled cd8a antibody
    A IOD of ACAT2 expression in CC tissues and adjacent tissues was examined using immunohistochemical staining ( n = 47 biologically independent samples). IOD of DHCR7 B and MSMO1 C expression in CC patients with high ( n = 27 biologically independent samples) or low ( n = 20 biologically independent samples) expression of ACAT2 was examined using immunohistochemical staining. The number of activated CD8 T cells <t>(CD8A</t> + GZMB + ) D or activated NK cells (CD56 + GZMB + ) E infiltrated in the tumor tissues of patients with high ( n = 27 biologically independent samples) and low ACAT2 ( n = 20 biologically independent samples) expression was detected. Data represent mean ± SEM. Statistical analysis was performed using the paired A or unpaired ( B – E ) t-test.
    Apc Coupled Cd8a Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/APC+Anti-mouse+CD8a/pmc12992596-312-43-48
    Average 93 stars, based on 1 article reviews
    apc coupled cd8a antibody - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Proteintech anti cd8 apc
    A IOD of ACAT2 expression in CC tissues and adjacent tissues was examined using immunohistochemical staining ( n = 47 biologically independent samples). IOD of DHCR7 B and MSMO1 C expression in CC patients with high ( n = 27 biologically independent samples) or low ( n = 20 biologically independent samples) expression of ACAT2 was examined using immunohistochemical staining. The number of activated CD8 T cells <t>(CD8A</t> + GZMB + ) D or activated NK cells (CD56 + GZMB + ) E infiltrated in the tumor tissues of patients with high ( n = 27 biologically independent samples) and low ACAT2 ( n = 20 biologically independent samples) expression was detected. Data represent mean ± SEM. Statistical analysis was performed using the paired A or unpaired ( B – E ) t-test.
    Anti Cd8 Apc, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8a+apc/APC+Anti-human+CD8a/pm41588655-69-47-49
    Average 94 stars, based on 1 article reviews
    anti cd8 apc - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured CD8 + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.

    Journal: iScience

    Article Title: Targeting KIF20A blocks lactylation modification to suppress immune escape in hepatocellular carcinoma

    doi: 10.1016/j.isci.2026.115372

    Figure Lengend Snippet: Glycolysis inhibition-mediated blockade of H3K18la in HCC cells restores the function of co-cultured CD8 + T cells (A) Schematic diagram of the experimental design. (B) Changes in lactate levels in Huh7 cells after treatment with 2-DG or oxamate. (C–E) Representative WB results showing the levels of Pan Kla and H3K18la in Huh7 cells treated with inhibitors. (F) Lactate levels in DKO cells with or without lactate supplementation. (G and H) WB analysis of the protein levels of LDHA, LDHB, Pan Kla, and H3K18la in DKO cells with or without lactate treatment. H3 and β-actin were used as loading controls for lactylation markers and LDH isoforms, respectively. (I) Colony formation assays show the proliferation of HCC cells (control group vs. DKO group) cultured alone or co-cultured with CD8 + T cells. (J) Quantitative analysis of the proliferation of co-cultured CD8 + T cells by FC. (K) FC analysis of the expression levels of GzMB (L) and IFN-γ (M) in co-cultured CD8 + T cells. All data are shown as mean ± SD. (B, D, E, and G) were analyzed using one-way ANOVA, (J) analyzed by two-way ANOVA, and (K) was analyzed by Student’s t test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001. Experiments were repeated three times.

    Article Snippet: APC Anti-Mouse CD8a Antibody , Elabscience , Cat# E-AB-F1104E; RRID: AB_3740201.

    Techniques: Inhibition, Cell Culture, Control, Expressing

    Knockdown of LDHA/B inhibits HCC growth by activating CD8 + T cell-mediated antitumor immunity (A) WB analysis of LDHA, LDHB, and β-actin (loading control) expression in control and LDHA/B DKO Hepa 1–6 cells. (B) Representative images of tumors dissected from tumor-bearing mice ( n = 6). Tumor weights (C), tumor growth curves (D), Kaplan-Meier survival curve ( n = 6) (E), and lactate contents in tumor tissues (F) of the control and LDHA/B DKO groups ( n = 6). (G) IHC staining of H3K18la and Pan Kla in tumor tissues (scale bars, 100 μm, n = 6). (H–M) FC analysis of tumor-infiltrating immune cells: TILs were isolated from control and LDHA/B-DKO tumors. FC plots (left) and quantitative statistics (right) show: the proportion of CD3 + CD8 + CTLs (H), the proportion of CD44hiCD62Llo effector memory CTLs (I), and the proportions of intratumoral GzMB + (J), and IFN-γ + (K) CTLs with representative scatterplots ( n = 6). Cell aggregates and debris were first excluded, followed by gating on the target cell populations and markers of interest. Representative FC plots and quantitative data are presented. (L and M) Tumor size and growth curves of mice treated with anti-CD8 antibody to deplete CD8 + T cells or isotype control (IgG) ( n = 6). (N) Mouse body weights at the end of the experiment ( n = 6). Data are presented as mean ± SD. (C–F, and H–M) were analyzed using Student’s t test, and (N) was analyzed by two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001; ns, not significant. All experiments were repeated three times. β-actin served as the loading control for WB experiments.

    Journal: iScience

    Article Title: Targeting KIF20A blocks lactylation modification to suppress immune escape in hepatocellular carcinoma

    doi: 10.1016/j.isci.2026.115372

    Figure Lengend Snippet: Knockdown of LDHA/B inhibits HCC growth by activating CD8 + T cell-mediated antitumor immunity (A) WB analysis of LDHA, LDHB, and β-actin (loading control) expression in control and LDHA/B DKO Hepa 1–6 cells. (B) Representative images of tumors dissected from tumor-bearing mice ( n = 6). Tumor weights (C), tumor growth curves (D), Kaplan-Meier survival curve ( n = 6) (E), and lactate contents in tumor tissues (F) of the control and LDHA/B DKO groups ( n = 6). (G) IHC staining of H3K18la and Pan Kla in tumor tissues (scale bars, 100 μm, n = 6). (H–M) FC analysis of tumor-infiltrating immune cells: TILs were isolated from control and LDHA/B-DKO tumors. FC plots (left) and quantitative statistics (right) show: the proportion of CD3 + CD8 + CTLs (H), the proportion of CD44hiCD62Llo effector memory CTLs (I), and the proportions of intratumoral GzMB + (J), and IFN-γ + (K) CTLs with representative scatterplots ( n = 6). Cell aggregates and debris were first excluded, followed by gating on the target cell populations and markers of interest. Representative FC plots and quantitative data are presented. (L and M) Tumor size and growth curves of mice treated with anti-CD8 antibody to deplete CD8 + T cells or isotype control (IgG) ( n = 6). (N) Mouse body weights at the end of the experiment ( n = 6). Data are presented as mean ± SD. (C–F, and H–M) were analyzed using Student’s t test, and (N) was analyzed by two-way ANOVA. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001; ns, not significant. All experiments were repeated three times. β-actin served as the loading control for WB experiments.

    Article Snippet: APC Anti-Mouse CD8a Antibody , Elabscience , Cat# E-AB-F1104E; RRID: AB_3740201.

    Techniques: Knockdown, Control, Expressing, Immunohistochemistry, Isolation

    KIF20A regulates PD-L1 expression via c-Myc (A and B) Huh7 and HCCLM3 cells were transfected with KIF20A small interfering RNAs (siRNAs) or KIF20A overexpression (OE) pcDNA3.1 plasmids, respectively. The protein levels of KIF20A, c-Myc, and PD-L1 were measured by WB in Huh7 and HCCLM3 cells. (C) ChIP-PCR was performed to assess the binding of c-Myc to the PD-L1 promoter region in Huh7 cells. (D) Huh7 cells were transfected with c-Myc siRNAs, and the knockdown efficiency of c-Myc was verified by RT-PCR. (E and F) Huh7 and HCCLM3 cells were co-transfected with KIF20A OE plasmids and c-Myc siRNAs. The protein levels of KIF20A, PD-L1, and c-Myc were determined by WB. (G) Huh7 cells were co-transfected with pGL3-PD-L1 or pGL3-basic plasmids, KIF20A OE pcDNA3.1 plasmids, c-Myc siRNAs, and pRL-TK plasmids, followed by luciferase activity assay. (H and I) KIF20A promotes HCC cell immune evasion by regulating PD-L1 expression via c-Myc. HCC cells from different groups were co-cultured with CD8 + T cells. Representative FC plots and quantitative analysis of GzMB and IFN-γ expression in CD8 + T cells co-cultured with Huh7 cells. (J and K) Representative images and quantitative analysis of colony formation in Huh7 cells with or without CD8 + T cell co-culture. Data are presented as mean ± SD. Statistical analyses were performed using Student’s t test (D), one-way ANOVA (C, I), or two-way ANOVA (G, K). ∗∗ p < 0.01 and ∗∗∗ p < 0.001. All experiments were repeated three times.

    Journal: iScience

    Article Title: Targeting KIF20A blocks lactylation modification to suppress immune escape in hepatocellular carcinoma

    doi: 10.1016/j.isci.2026.115372

    Figure Lengend Snippet: KIF20A regulates PD-L1 expression via c-Myc (A and B) Huh7 and HCCLM3 cells were transfected with KIF20A small interfering RNAs (siRNAs) or KIF20A overexpression (OE) pcDNA3.1 plasmids, respectively. The protein levels of KIF20A, c-Myc, and PD-L1 were measured by WB in Huh7 and HCCLM3 cells. (C) ChIP-PCR was performed to assess the binding of c-Myc to the PD-L1 promoter region in Huh7 cells. (D) Huh7 cells were transfected with c-Myc siRNAs, and the knockdown efficiency of c-Myc was verified by RT-PCR. (E and F) Huh7 and HCCLM3 cells were co-transfected with KIF20A OE plasmids and c-Myc siRNAs. The protein levels of KIF20A, PD-L1, and c-Myc were determined by WB. (G) Huh7 cells were co-transfected with pGL3-PD-L1 or pGL3-basic plasmids, KIF20A OE pcDNA3.1 plasmids, c-Myc siRNAs, and pRL-TK plasmids, followed by luciferase activity assay. (H and I) KIF20A promotes HCC cell immune evasion by regulating PD-L1 expression via c-Myc. HCC cells from different groups were co-cultured with CD8 + T cells. Representative FC plots and quantitative analysis of GzMB and IFN-γ expression in CD8 + T cells co-cultured with Huh7 cells. (J and K) Representative images and quantitative analysis of colony formation in Huh7 cells with or without CD8 + T cell co-culture. Data are presented as mean ± SD. Statistical analyses were performed using Student’s t test (D), one-way ANOVA (C, I), or two-way ANOVA (G, K). ∗∗ p < 0.01 and ∗∗∗ p < 0.001. All experiments were repeated three times.

    Article Snippet: APC Anti-Mouse CD8a Antibody , Elabscience , Cat# E-AB-F1104E; RRID: AB_3740201.

    Techniques: Expressing, Transfection, Over Expression, Binding Assay, Knockdown, Reverse Transcription Polymerase Chain Reaction, Luciferase, Activity Assay, Cell Culture, Co-Culture Assay

    A IOD of ACAT2 expression in CC tissues and adjacent tissues was examined using immunohistochemical staining ( n = 47 biologically independent samples). IOD of DHCR7 B and MSMO1 C expression in CC patients with high ( n = 27 biologically independent samples) or low ( n = 20 biologically independent samples) expression of ACAT2 was examined using immunohistochemical staining. The number of activated CD8 T cells (CD8A + GZMB + ) D or activated NK cells (CD56 + GZMB + ) E infiltrated in the tumor tissues of patients with high ( n = 27 biologically independent samples) and low ACAT2 ( n = 20 biologically independent samples) expression was detected. Data represent mean ± SEM. Statistical analysis was performed using the paired A or unpaired ( B – E ) t-test.

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: A IOD of ACAT2 expression in CC tissues and adjacent tissues was examined using immunohistochemical staining ( n = 47 biologically independent samples). IOD of DHCR7 B and MSMO1 C expression in CC patients with high ( n = 27 biologically independent samples) or low ( n = 20 biologically independent samples) expression of ACAT2 was examined using immunohistochemical staining. The number of activated CD8 T cells (CD8A + GZMB + ) D or activated NK cells (CD56 + GZMB + ) E infiltrated in the tumor tissues of patients with high ( n = 27 biologically independent samples) and low ACAT2 ( n = 20 biologically independent samples) expression was detected. Data represent mean ± SEM. Statistical analysis was performed using the paired A or unpaired ( B – E ) t-test.

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Expressing, Immunohistochemical staining, Staining

    ACAT2 expression in HCeEpiC and CC cell lines was examined using RT-qPCR A and Western blot analysis B ( n = 5 independent experiments). C ACAT2, DHCR7, and MSMO1 expression in CC cells after infection with Scramble-sh, ACAT2-sh #1, and ACAT2-sh #2 was examined using Western blot analysis ( n = 5 independent experiments). D Detection of total cholesterol, free cholesterol, and cholesteryl ester levels in CC cells ( n = 5 independent experiments). The proliferation of CC cells was examined using CCK8 ( E ) and colony formation assays F (n = 5 independent experiments). G CC cells were co-cultured with (E: T = 3:1) with NK cells or CD8 T cells for 6 h, respectively, and the death of CC cells was detected ( n = 5 independent experiments). H IFN-γ and GZMB released from immune cells in a co-culture system with CC cells were examined using ELISA ( n = 5 independent experiments). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( A , B ) or two-way ( C - H ) ANOVA, followed by Tukey’s multiple comparisons test ( A – H ).

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: ACAT2 expression in HCeEpiC and CC cell lines was examined using RT-qPCR A and Western blot analysis B ( n = 5 independent experiments). C ACAT2, DHCR7, and MSMO1 expression in CC cells after infection with Scramble-sh, ACAT2-sh #1, and ACAT2-sh #2 was examined using Western blot analysis ( n = 5 independent experiments). D Detection of total cholesterol, free cholesterol, and cholesteryl ester levels in CC cells ( n = 5 independent experiments). The proliferation of CC cells was examined using CCK8 ( E ) and colony formation assays F (n = 5 independent experiments). G CC cells were co-cultured with (E: T = 3:1) with NK cells or CD8 T cells for 6 h, respectively, and the death of CC cells was detected ( n = 5 independent experiments). H IFN-γ and GZMB released from immune cells in a co-culture system with CC cells were examined using ELISA ( n = 5 independent experiments). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( A , B ) or two-way ( C - H ) ANOVA, followed by Tukey’s multiple comparisons test ( A – H ).

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Expressing, Quantitative RT-PCR, Western Blot, Infection, Cell Culture, Co-Culture Assay, Enzyme-linked Immunosorbent Assay

    A ACAT2 knockdown efficiency in U14 cells was examined using western blot analysis ( n = 10 independent experiments). B Volume changes of transplanted tumors in mice subcutaneously inoculated with U14 cells (n = 10 animals). C The images and weight of the tumors harvested on day 21 ( n = 10 animals). D Protein expression of ACAT2, MSMO1, DHCR7, and PCNA in transplanted tumors was examined using western blot analysis ( n = 10 animals). E Detection of total cholesterol, free cholesterol, and cholesteryl ester levels in transplanted tumors ( n = 10 animals). The gating strategy for GZMB + NK cells and CD8 + T cells F and quantification G were analyzed using flow cytometry ( n = 10 animals). H Survival of mice over 60 days after subcutaneous inoculation of U14 cells was analyzed using the log-rank test ( n = 20 animals). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( A , C , E , G ) or two-way ( B , D ) ANOVA, followed by Tukey’s multiple comparisons test.

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: A ACAT2 knockdown efficiency in U14 cells was examined using western blot analysis ( n = 10 independent experiments). B Volume changes of transplanted tumors in mice subcutaneously inoculated with U14 cells (n = 10 animals). C The images and weight of the tumors harvested on day 21 ( n = 10 animals). D Protein expression of ACAT2, MSMO1, DHCR7, and PCNA in transplanted tumors was examined using western blot analysis ( n = 10 animals). E Detection of total cholesterol, free cholesterol, and cholesteryl ester levels in transplanted tumors ( n = 10 animals). The gating strategy for GZMB + NK cells and CD8 + T cells F and quantification G were analyzed using flow cytometry ( n = 10 animals). H Survival of mice over 60 days after subcutaneous inoculation of U14 cells was analyzed using the log-rank test ( n = 20 animals). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( A , C , E , G ) or two-way ( B , D ) ANOVA, followed by Tukey’s multiple comparisons test.

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Knockdown, Western Blot, Expressing, Flow Cytometry

    The proliferation of CC cells was examined using CCK8 A and colony formation assays B ( n = 5 independent experiments). C CC cells were co-cultured with (E: T = 3:1) with NK cells or CD8 + T cells, and the death of CC cells was detected ( n = 5 independent experiments). D IFN-γ and GZMB released from immune cells in a co-culture system with CC cells were examined using ELISA ( n = 5 independent experiments). E TGF-β1 released by CC cells was examined using ELISA ( n = 5 independent experiments). F PD-L1 expression levels in CC cells were observed using immunofluorescence staining ( n = 5 independent experiments). Data represent mean ± SEM. Statistical analysis was performed using the two-way ( A – F ) ANOVA, followed by Tukey’s multiple comparisons test.

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: The proliferation of CC cells was examined using CCK8 A and colony formation assays B ( n = 5 independent experiments). C CC cells were co-cultured with (E: T = 3:1) with NK cells or CD8 + T cells, and the death of CC cells was detected ( n = 5 independent experiments). D IFN-γ and GZMB released from immune cells in a co-culture system with CC cells were examined using ELISA ( n = 5 independent experiments). E TGF-β1 released by CC cells was examined using ELISA ( n = 5 independent experiments). F PD-L1 expression levels in CC cells were observed using immunofluorescence staining ( n = 5 independent experiments). Data represent mean ± SEM. Statistical analysis was performed using the two-way ( A – F ) ANOVA, followed by Tukey’s multiple comparisons test.

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Cell Culture, Co-Culture Assay, Enzyme-linked Immunosorbent Assay, Expressing, Immunofluorescence, Staining

    A Volume changes of transplanted tumors in mice subcutaneously inoculated with U14 cells ( n = 5 animals). B The images and weight of the tumors harvested on day 21 ( n = 5 animals). The gating strategy for GZMB + NK cells and CD8 + T cells C and quantification D were analyzed using flow cytometry ( n = 5 animals). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( B , D ) or two-way A ANOVA, followed by Tukey’s multiple comparisons test.

    Journal: Communications Biology

    Article Title: SREBF2 enhances lipid metabolism and represses anti-tumor immune responses in cervical cancer by increasing ACAT2

    doi: 10.1038/s42003-026-09678-9

    Figure Lengend Snippet: A Volume changes of transplanted tumors in mice subcutaneously inoculated with U14 cells ( n = 5 animals). B The images and weight of the tumors harvested on day 21 ( n = 5 animals). The gating strategy for GZMB + NK cells and CD8 + T cells C and quantification D were analyzed using flow cytometry ( n = 5 animals). Data represent mean ± SEM. Statistical analysis was performed using the one-way ( B , D ) or two-way A ANOVA, followed by Tukey’s multiple comparisons test.

    Article Snippet: The cell suspension (100 μL) was incubated with BeyoFC Fc Receptor Blocking Solution (C1755, Beyotime) for 10 min at 4 °C and with primary antibodies, including FITC-coupled CD3 antibody (1:100, FITC-65077, ProteinTech, RRID: AB_2883763), PE-coupled NK1.1 antibody (1:100, PE-65138, ProteinTech, RRID: AB_2883920), and APC-coupled CD8A antibody (1:100, APC-65069, ProteinTech, RRID: AB_2882970) for 1 h at 4 °C.

    Techniques: Flow Cytometry